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TREIT, D., K. C. BERRIDGE AND C. E. SCHULTZ.  The direct enhancement of positive palatability by chlor- 
diazepoxide is antagonized by Ro 15-1788 and CGS 8216. PHARMACOL BIOCHEM BEHAV 26(4)709--71.4. 1987.~In a 
previous study, it was found that positive, palatability-dependent consummatory reactions in rats to intraoraUy infused 
tastes were facilitated by chlordiazepoxide (10 mg/kg). In contrast, the rats' more neutral or aversive reactions to these 
tastes were not facilitated by chlordiazepoxide. This suggested that chiordiazepoxide might selectively enhance the posi- 
tive palatability of tastes. This effect was replicated in the present experiment, and in addition, the benzodiazepine 
antagonists Ro 15-1788 and CGS 8216 were found to counteract the enhancement of positive ingestive reactions produced 
by chlordiazepoxide. These antagonist effects generally suggest that the benzodiazepine receptor complex may be involved 
in making tastes more palatable after chlordiazepoxide administration. 
Palatability Chlordiazepoxide Ro 15-1788 CGS 8216 
IT is well known that anxiolytics such as the ben- measure of consummatory motivation that is independent 
zodiazepines and barbiturates tend to increase food or fluid fear motivation. 
intake in a wide variety of species, including mice, rats, Recently, Berridge and Treit [8] suggested that an int] 
hamsters, pigeons, cats, dogs, sheep, horses, monkeys, and oral, taste-infusion paradigm [28,29] provides a useful way 
humans [1--4, 10, 13, 15, 17, 20, 21, 24, 26, 27, 32, 35, 37, 39]. determine whether or not anxiolytics directly facilitate cc 
Nevertheless, the general mechanisms that might mediate summatory motivation (e.g., increase appetite). In tl 
intake facilitation by anxiolytics remain controversial (see paradigm, solutions of different taste (e.g., sucrose, sa 
[19] for a recent review), quinine) are infused into the rat 's mouth through intrao: 
Although there are a number of plausible interpretations cannulae. The rat 's species-typical response to these infus 
of this facilitative effect [19], two contrasting views are dom- tastes (e.g., lateral tongue protrusions, face-washir 
inant. The first view is that facilitation is due to a direct, forelimb flailing)correspond quite closely with normal inta 
drug-induced increase in the motivation to consume foods of solutions of these tastes [9], as well as with humans'  r~ 
and/or fluids (e.g., increased "appeti te";  [18]). The second is ings of  the hedonic values of these tastes [6,14]. But the m( 
that facilitation is an indirect consequence of  an "anti- important advantage of the taste-infusion paradigm is thai 
anxiety" drug effect: Anxiolytics reduce "fearful" or "aver- is particularly sensitive to variables that directly affc 
s ire" aspects of the test situation (e.g., novelty, painful palatability, in contrast to the more diffuse variables that c 
stimulation), which otherwise suppress consumption (e.g., indirectly affect food intake, such as anxiety or fear [8,32 
[12,36]. Using this paradigm, Berridge and Treit found that t 
Until recently, intake measures have been the primary prototypical anxiolytic, chlordiazepoxide (CDP), signi 
source of support for each of these contrasting views (e.g., eantly increased "posit ive" taste reactions (i.e., "ingesti 
[23,36]), However, simple intake measures cannot discrimi- actions"), while having little or no effect on "neutral" 
hate between the appetite-enhancing effects of drugs, the "aversive" taste reactions. This facilitation of  ingesti 
anti-anxiety effects, or the combination of  these effects, reactions occurred with every taste tested. These resu 
Thus, a resolution to this ambiguity seems to depend on a strongly suggested that anxiolytics such as CDP enhance t 
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positive palatability of tastes, and in this way increase the and immediately injected in a volume of 1 ml/kg, wher~ 
hedonic or reinforcing value of  tbods or fluids. CDP was simply dissolved in saline and injected in a volul 
In addition to providing a fairly strong argument against of I ml/kg. Agonists and antagonists were injected 30 n 
the use of paradigms that involve food or fluid reinforcement before the taste test. 
to test "anxiolytic '"  drug effects (e.g., the Geller " 'conflict" Previous studies have shown 10 mg/kg CDP to be witl 
test), the results of  the Berridge and Treit study suggest that the range that reliably promotes consummatory-related I 
the " 'GABA/benzodiazepine-receptor-complex" [30,34], havior in rats [15, 17, 18.20.21, 23]. The doses of Ro 15-15 
where CDP acts as an agonist, might be importantly involved and CGS 8216 chosen in the present study are clearly witl 
in the modulation of food and fluid reinforcement, (cf. [19]). the range where the facilitative effects of benzodiazepines 
Stronger evidence of  this relationship would be provided, consumption can be reliably inhibited [19], in many ca~ 
however, by demonstrating that benzodiazepine antagonists,  without "'intrinsic" inhibitory, effects on consumption [ 
such as Ro 15-1788 [30] or CGS 8216 [l I] could inhibit the 19, 22]. However.  recent studies indicate that CGS 8216 c 
selective facilitation of ingestive reactions produced by have intrinsic (i.e., " inverse agonist")  effects on consu 
CDP. Thus, the purpose of this experiment was to investi- matory behavior. For example.  CGS 8216 by itself can 
gate the effects of Ro 15-1788 and CGS 8216 on the facilita- hibit consummatory behavior in rats [5], especially when I 
tion of rats '  positive ingestive actions induced by CDP. ingested substances are highly palatable [25.31]. Thus, 
though the primary question of this study is simply whetl 
benzodiazepine antagonists will inhibit the effects of CDP 
METHOD rats" positive reactions to infused tastes, a related questior 
whether antagonistic effects, especially those of CGS 82 
Animals will be accompanied by inverse agonist effects, previou 
Twelve. naive, male Sprague-Dawley rats (250-350 g), demonstrated in simple intake paradigms (e.g., [31]). 
purchased from Charles River Laboratories were housed in Before the first test phase, each rat received three injectk 
groups of two throughout all phases of  the experiment,  under of 10 mg/kg CDP over three consecutive days in order 
a 12/12 hr light cycle (lights on 7:00 a.m.). Purina rat chow minimize any initial sedative effects of the drug (cf, [8]). 
and water were available ad lib. addition, during the two days immediately preceding the t 
periment, the rats were individually placed into the rouz 
Plexiglas test chamber, with cannulae connected to a ta 
Cannltltte Implantation solution delivery tube, then allowed a 5 min habituation 
Animals were surgically implanted with bilateral, intra- the chamber,  after which a 1 ml volume of distilled water v 
oral  cannu lae ,  under  ke t amine  (100 mg/kg) and ace-  infused into the rats" mouth, at a constant rate over  1 n 
promazine (1 mg/kg) anaesthesia, according to procedures li.e.,  the same procedure used for subsequent presentati 
described by Grill and Norgren [29]. The cannulae enter  the of taste stimuli). 
head dorsally, where they are anchored to the skull with Behavioral Measures and Statistical Analysis 
stainless steel screws and acrylic cement. They then enter 
the mouth just  lateral to the first maxillary molar. Fine tubing During the 10 rain of each test, each rat was scored for I 
(PE 10) can be fitted inside the cannulae, which allows the occurrence of ingestive, neutral, and aversive actions ( 
infusion of  the taste solutions [29], [8]). Briefly, these actions were scored as (1) ingestive (i. 
paw licking: lateral tongue protrusions: and midline ton~ 
protrusions~. ~2) neutral (rhythmic mouth movement with~ 
7~ste Stimuli and Dru~, Administration tongue protrusion: passive drip of the fluid from the mout 
The taste stimuli used in the present study were the same (3) aversive (gapes: large openings of  the mandible with 
as those used in the Berridge and Treit study: 0.03 M su- traction of the lower lips: chin rubbing: bringing the mouth 
crose, which primarily elicits ingestive actions: 0.01 M HCI. contact with the floor and projecting the body forward; fc 
which elicits ingestive and aversive reactions: and 3 × 10 -~ M washing: forelimb flails: shaking of the forelimb with a f 
quinine HCI. which typically elicits aversive reactions, quency greater than 60 Hz: headshaking: at a frequen 
These particular concentrations were chosen in order to greater than 60 Hz: paw treading: planting of the forelirc 
avoid possible ceiling effects, which might tend to obscure on the floor and alternating strokes forward and back: a 
any facilitative effect of  CDP (cf. [8]). rapid locomotor movement about the chamber (see [28.: 
The experiment included two phases. In Phase I. the 12 for further information on the classification of these action 
rats were injected with CDP. saline. Ro 15-1788, and the Videotapes of these behaviors were scored at %0 spe 
combination of Ro 15-1788 and CDP, in a randomized order, by an observer  blind to the drug condition of the rats. 
In Phase II, seven of these rats still had operational can- stances of ingestive, neutral, and aversive reactions um 
nulae, and subsequently were subjected to the same drug each of the taste and drug conditions were scored for e~ 
regimen, except that CGS 8216 was injected instead of Ro animal. For the purpose of quantifying the number of 
15-1788. During each phase, each taste stimulus was pre- sponses emitted, discrete actions such as lateral ton~ 
sented four times, on consecutive days: once after the rat protrusions, gapes, chin rubs, bouts of face washi~ 
had received an intraperitoneal lIP) injection of  10 mg/kg of forelimb flailing, headshakes,  paw treading, and locomoti 
CDP: once 'after an IP injection of an equal volume ( 1 ml/kg) were recorded each time they occurred. Continuous actic 
of isotonic saline: once alter an IP injection of 10 mg/kg of that typically persist for relatively long periods were 
the antagonist Ro 15-1788 (Phase I) or 10 mg/kg CGS 8216 corded as follows: paw licks, mouth movements,  and pass~ 
(Phase II): and once after an IP injection of the combination dripping were recorded in 5-sec bins (any occurrence 
of 10 mg/kg CDP and I0 mg/kg Ro 15-1788 (Phase I) or 10 these behaviors up to 5 sec duration was counted as a sin 
mg/kg of CDP and 10 mg/kg of CGS 8216 (Phase IlL The occurrence). Rhythmic tongue protrusions were scored 
antagonists were suspended in saline by untrasonification the same way in 2-sec bins. The sum of behaviors in e~ 
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TABLE 1 
ANALYSIS OF THE RESULTS OF PHASE I 
Taste Reaction af F p Newman-Keuls p<0.05 
0.03 M Sucrose Ingestive 3.33 9.53 <0.001 CP>SA: RO+CP<CP: 
RO~SA 
Neutral 3.33 2.66 >0.06 nit 
Aversive 3.33 1.65 >0.19 nil 
0.01 M HCI Ingestive 3.33 7.97 <0.001 CP>SA; RO+CP>SA 
Neutral 3.33 0,77 >0.5 nil 
Aversive 3.33 1.88 >0.1 nil 
3x 10-:' M QHCI Ingestive 3.33 16.57 <0.001 CP~SA; RO+CP<CP 
Neutral 3.33 11.38 <0.001 CP<SA; RO+CP>CP 
Aversive 3.33 1.69 >0.18 nil 
Chlordiazepoxide (CPI: Saline (SA): Ro 15-1788 (RO); Ro 15-1788 + Chlordiazepoxide 
(RO+CP). 
TABLE 2 
ANALYSIS OF THE RESULTS OF PHASE I1, WHERE COS 8216 (CG) IS SUBSTITUTED 
FOR Ro 15-1788 
Taste Reaction df F p Newman-Keuls p <0.05 
0.03 M Sucrose Ingestive 3.18 8.83 <0.001 CP>SA; CG+CP>CP' 
Neutral 3,18 4.64 <0.01 CP<CG; CG>SA 
Aversive 3,18 2.70 >0.07 nil 
0.01 M HC1 Ingestive 3,18 10.3 <0.001 CP>SA; CG+CP<CP 
Neutral 3.18 6.54 <0.003 CP<SA; CG+CP>CP 
Aversive 3.18 1.15 >0.35 nil 
3x 10 -~ M Q H C 1  Ingestive 3.18 10.4 <0.001 CP>SA; CG+CP<CP 
Neutral 3,18 5.57 <0.007 CP<SA; CG+CP>CP 
Aversive 3,18 1.52 >0.24 nil 
category for each animal were then analyzed with one-way CDP compared to saline (see analyses in Table 1). Also cc 
repeated measures analyses of  variance, with four levels sistent with our previous study was the selectivity of tl 
representing each of the four drug conditions (chlor- facilitative effect of CDP. There was no facilitation by CI 
diazepoxide,  saline, antagonist,  and the combination of of the neutral or aversive reactions elicited by the thr 
chlordiazepoxide and antagonist). When these analyses tastes; in fact, there was a general tendency for neutral re,' 
yielded significant F values (Tables 1 and 2), the data were tions to be reduced by CDP (Fig. 1). However ,  as we fou 
further analyzed with Newman-Keuls  pair-wise comparisons previously, the suppressive effects of  CDP on non-ingesti 
(p =0.05), An antagonism of CDP was indicated by (I) a sig- actions was less robust than the facilitation of CDP on ing~ 
nificant difference between the combination of CDP + an- rive actions, and was significant in the present study only 
tagonist vs. CDP, and (2) no significant difference between the case of neutral reactions elicited by QHCI (Table 1). 
the combination vs. saline. An intrinsic effect of the an- In general, Ro 15-1788 antagonized the taste-specific 
tagonist itself was indicated by a significant difference be- fects of CDP on rats '  consummatory reactions (Fig. 1). ] 
tween it and saline. 15-1788 significantly antagonized the facilitative effect 
CDP on the ingestive reactions elicited by sucrose, 
quinine, but not by HCI (Fig. 1; Table 1). As expected on t 
RESULTS basis of the lack of  inverse agonist effects in previc 
Figure 1 shows the effects of the four drug conditions of consummatory-related paradigms [19], there was no hint 
Phase I on the consummatory reactions elicited by each of the present  study that Ro 15-1788 exerted inverse agon 
the three tastes. The facilitative effect of CDP on ingestive effects on ingestive reactions. On the contrary,  the only s 
reactions to sucrose, HCI, and QHCI, found in our previous nificant intrinsic effect of  Ro 15-1788 was actually parallel 
study, was completely replicated in the present study, i.e., its significant antagonism of  the facilitative effect of CDP 
ingestive reactions to all three flavors were facilitated by ingestive reactions, i.e., when compared to saline, Ro i 
712 TREIT, BERRIDGE AND SCHUL'I  
O 03 M SUCROSE 
0 03 M SUCROSE 
INGESTIVE NEUTRAL AVERSIVE 
30 




CP SA RO RO CP SA RO RO CP SA RO RO CP SA CG CG CP SA CG CG CP SA CG CG + . ÷ 





O 0 C1 M HCL t~ 001 171 HCL 
n CO 
CO INGESTIVE NEUTRAL AVERSIVE I l l  (~  INGESTIVE NEUTRAL AVERSIVE 
I I I  25 25 
20 LI. u_.  O 20 
O 15 15 
rr 
nllRr  m 3 rh 
~)  CP SA RO RO CP SA RO RO CP SA RO RO Z CP SA CG CG CP SA CG CG CP SA CG CG 
z cP c*p c+p c*P c*p c*p 
z 
z '< < uJ 
I11 3×10 "~ M QHCL ~ 3x10 -5 QHCL 




° n 11Jl ' ll 
CP SA RO RO CP SA RO RO CP SA NO RO CP SA CG CG CP SA CG CG CP SA CG CG 
Cp CP CP C, CP c*p 
D R U G  C O N D I T I O N  D R U G  C O N D I T I O N  
FIG. 1. The mean (=SEM)  of  each of  the three consummatory reac- FIG. 2. The mean (__SEM) ot'each of  the three consummatory rea 
[ions, under each of the three taste conditions and each of  the four [ions. under each of the three taste conditions and each of  the t'o 
drug conditions of  Phase [, CP= I0  rn~'kg chlordiazepo×ide: drug condi t ions of  Phase H. C P = I 0  ras/kg chlord iazepoxid 
SA=sal ine; R O = I 0  ms/kg Ro 15-1788:RO+CP=I0  ms/kg Ro 15- SA=saline',CG=IOms/kgCGS8216:CG+CP=IOms/kgCGS82 
1788 + 10 rn~kg chlordiazepoxide. + 10 m6/kg chlordiazepo×ide. 
1788 facilitated the ingestive reactions to sucrose. This was again replicated, with CDP in each case producing 
agonist-like effect of Ro 15-1788 has been demonstrated in a significant facilitation compared to saline. CGS 8216 consi 
previous taste study [38], perhaps suggesting that under re- tently antagonized these facilitative effects of CDP, and in z 
stricted taste parameters (e.g.. 0.03 M sucrose) Ro 15-1788 case did CGS 8216 have an intrinsic inhibitory effect by 
might be characterized as a mixed agonist/antagonist. Fi- self. 
nally. Ro 15-1788 reversed the significant reduction in neu- Also consistent with the results shown in Fig. 1 was tl 
tral reactions to QHCI produced by CDP, without a signifi- general suppression of neutral reactions produced by c r  
cant intrinsic effect. There were no significant effects of any (Fig. 2). CDP produced a significant reduction in neutr 
of  the drug conditions on aversive reactions elicited by the reactions to HC1 and to QHCI. but not to sucrose (Table Z 
three tastes (Table 1). These inhibitory effects of CDP on neutral reactions we 
Figure 2 shows the effects of the tour drug conditions of significantly antagonized by CGS 8216. and CGS 8216 had t 
Phase II on the consummatory reactions elicited by the three intrinsic effect on these reactions. In contrast,  CGS 82 
tastes, where CGS 8216 was substituted for Ro 15-1788. The produced a significant enhancement of the neutral reactio~ 
results with CGS 8216 generally parallel those of Ro 15-1788 elicited by sucrose. Finally, consistent with the results 
displayed in Fig. 1. ANOVAs and subsequent Newman- Phase I. none of the four drug conditions of Phase II pr, 
Keuls comparisons (Table 2) showed that the facilitation by duced a significant effect on the aversive reactions elicit~ 
CDP of  the ingestive reactions to each of the three flavors by the three tastes (Table 2). 
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DISCUSSION produced only one intrinsic effect of any kind. Like CC 
8216, Ro 15-1788 did not appear to display inverse agon 
There were several noteworthy findings in the present effects in the taste infusion paradigm; instead, it produced 
study. First, the direct facilitation of positive palatability intrinsic facilitation of ingestive reactions to sucrose (~ 
reactions by CDP was consistently replicated with every [38]). Further work is needed in order to understand the 
taste tested (cf. [8]). As we found in our previous study, the effects of Ro 15-1788 and CGS 8216 in the taste-infusi, 
enhancement of taste-elicited ingestive actions was selec- paradigm, and the relation of these to their effects in simr 
tive; neutral and aversive actions were not enhanced by intake paradigms. 
CDP. Rather. non-ingestive actions were either not altered Another noteworthy finding was that these two be 
or else suppressed after CDP. This special sensitivity of in- zodiazepine antagonists inhibited both the increases and tl 
gestive actions to enhancement by CDP supports our earlier decreases in consummatory reactions produced by CD 
suggestion that benzodiazepines promote feeding in part by Thus, the results are difficult to explain in terms of an und 
selectively amplifying the perceived positive palatability of tected, general effect of the antagonists (e.g., proconvulsa 
foods, while having little or no effect on the negative or or anxiogenic), which might have indirectly mediated th~ 
aversive aspects of palatability. This interpretation is con- antagonist actions on CDP. Instead, the effects found in t 
sistent with the model of separate parallel processing of present study appear to reflect actions at the benzodiazepi 
positive and negative palatability, presented by Berridge and receptor complex. Accordingly, the results of our expe 
Grill [7]. ments [8], and the recent work of Cooper and his associat 
Second, this selective increase in positive palatability (e.g., [19,31]) suggest the following hypothesis: The neul 
reactions produced by CDP was, in five out of six tests, control of ingestive responses that is exerted by the be 
uniformly counteracted by the benzodiazepine antagonists zodiazepine receptor complex is due in part to its modulati, 
Ro 15-1788 and CGS 8216. suggesting that the " b e n -  of the positive palatability of tastes (cf. [19]). 
zodiazepine receptor complex" might be involved in mod- 
ulating the hedonic value of specific tastes. CGS 8216, also 
known for its inverse agonist effects on the intake of palata- ACKNOWLEDGEMENTS 
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